ARHGAP9 may be used as a novel prognostic biomarker associated with tumor immunity and cellular composition in ccRCC
Saved in:
| Main Authors: | Yini Wang, Wenyu Wang, Xiaohong Ma, Jitao Wu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-05-01
|
| Series: | Asian Journal of Surgery |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1015958424028458 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CircABCA1 promotes ccRCC by reprogramming cholesterol metabolism and facilitating M2 macrophage polarization through IGF2BP3-mediated stabilization of SCARB1 mRNA
by: Hao Ning, et al.
Published: (2025-07-01) -
Association of HLA-DRA expression with prognosis and tumor microenvironment in clear cell renal cell carcinoma
by: Shu-Xin Qu, et al.
Published: (2025-08-01) -
Bioinformatics analysis of COMMD family in pan-cancer reveals potential biomarkers and therapeutic targets
by: Sihan Wang, et al.
Published: (2025-07-01) -
Gender-specific insights into TTN mutation: potential biomarker for female risk in kidney renal clear cell carcinoma
by: Ayan Saha, et al.
Published: (2025-09-01) -
GPD1L as a potential biomarker associated with Treg cell infiltration and lipid metabolism in clear cell renal cell carcinoma
by: Ming Yang, et al.
Published: (2025-08-01)